Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H4ClNOS |
| Molecular Weight | 149.599 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1SC(Cl)=CC1=O
InChI
InChIKey=DHNRXBZYEKSXIM-UHFFFAOYSA-N
InChI=1S/C4H4ClNOS/c1-6-4(7)2-3(5)8-6/h2H,1H3
| Molecular Formula | C4H4ClNOS |
| Molecular Weight | 149.599 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.cosmeticsinfo.org/ingredient/methylisothiazolinone-and-methylchloroisothiazolinoneCurator's Comment: description was created based on several sources, including:
DOI: 10.1007/978-3-642-55706-4_7
http://ec.europa.eu/consumers/sectors/cosmetics/files/pdf/mci_mi/mci_mi_pc_en.pdf
Methylisothiazolinone/Methylchloroisothiazolinone (Kathon CG) Allergy: An Updated Review.
Sources: http://www.cosmeticsinfo.org/ingredient/methylisothiazolinone-and-methylchloroisothiazolinone
Curator's Comment: description was created based on several sources, including:
DOI: 10.1007/978-3-642-55706-4_7
http://ec.europa.eu/consumers/sectors/cosmetics/files/pdf/mci_mi/mci_mi_pc_en.pdf
Methylisothiazolinone/Methylchloroisothiazolinone (Kathon CG) Allergy: An Updated Review.
Methylchloroisothiazolinone is an active ingredient in many preservatives marketed under various brand names. It is effective against gram-positive and gram-negative bacteria, yeast, and fungi. Pure Methylchloroisothiazolinone is not commercially available. Kathon CG contains a mixture of Methylisothiazolinone (MI) and Methylchloroisothiazolinone (MCI) in ratio 3:1. Kathon was used in various rinse-off and leave-on formulations including hair products, shampoos, skin care products, bath products, eye and facial makeup, wet wipes and suntan products. The Commission envisages amending Annex V of the Cosmetics Regulation (EC) No. 1223/2009 to restrict the use of methylchloroisothiazolinone to rinse-off products, as suggested by the SCCS.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0009060 Sources: http://www.ppchem.com/free/ppchem-01-2007-2.pdf |
|||
Target ID: CHEMBL2096668 Sources: http://www.ppchem.com/free/ppchem-01-2007-2.pdf |
|||
Target ID: ATP synthesis Sources: http://www.ppchem.com/free/ppchem-01-2007-2.pdf |
|||
Target ID: GO:1903409 Sources: http://www.ppchem.com/free/ppchem-01-2007-2.pdf |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | TRUE Test Approved Use5-chloro-2-methyl-4-isothiazolin-3-one (1.05% to 1.25% w/w) and 2-methyl-4-isothiazolin-3-one (0.25% to 0.40%
w/w) in a 3:1 ratio at a concentration of 1.5% in aqueous magnesium salts are used to formulate patch #17 |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
282 μg/g EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/28929222/ |
2 mg single, oral dose: 2 mg route of administration: Oral experiment type: SINGLE co-administered: |
N-METHYLMALONAMIC ACID urine | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
7.6 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/28929222/ |
2 mg single, oral dose: 2 mg route of administration: Oral experiment type: SINGLE co-administered: |
N-METHYLMALONAMIC ACID urine | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Doses
| Dose | Population | Adverse events |
|---|---|---|
1000 ppm single, topical Highest studied dose Dose: 1000 ppm Route: topical Route: single Dose: 1000 ppm Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: unknown Food Status: UNKNOWN Sources: |
Other AEs: Sensitization... Other AEs: Sensitization (12.5%) Sources: |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Sensitization | 12.5% | 1000 ppm single, topical Highest studied dose Dose: 1000 ppm Route: topical Route: single Dose: 1000 ppm Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: unknown Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Chemical allergens stimulate human epidermal keratinocytes to produce lymphangiogenic vascular endothelial growth factor. | 2015-03-01 |
|
| B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry. | 2012-03-25 |
|
| The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study in five laboratories. | 2011-04 |
|
| Analysis of isothiazolinone biocides in paper for food packaging by ultra-high-performance liquid chromatography-tandem mass spectrometry. | 2010-12 |
|
| Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes. | 2010-11-10 |
|
| Prevalence and cause of methylisothiazolinone contact allergy. | 2010-09 |
|
| A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. | 2010-09 |
|
| Methylchloroisothiazolinone / methylisothiazolinone and moist wipe dermatitis. | 2010-05-15 |
|
| Consumer exposure to biocides--identification of relevant sources and evaluation of possible health effects. | 2010-02-03 |
|
| Concomitant contact allergy to methylchloroisothiazolinone/methylisothiazolinone and formaldehyde-releasing preservatives. | 2010-01 |
|
| Mechanistic assessment of peptide reactivity assay to predict skin allergens with Kathon CG isothiazolinones. | 2009-04 |
|
| Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals. | 2009-04 |
|
| Role of intracellular calcium and S-glutathionylation in cell death induced by a mixture of isothiazolinones in HL60 cells. | 2009-03 |
|
| Methyl gallate. | 2009-01-14 |
|
| Alkalization of wall paint prevents airborne contact dermatitis in patients with sensitization to isothiazolinones. | 2008-08 |
|
| Suitability of macrophage inflammatory protein-1beta production by THP-1 cells in differentiating skin sensitizers from irritant chemicals. | 2008-04 |
|
| Airborne allergic contact dermatitis to methylchloroisothiazolinone/methylisothiazolinone in ironing water. | 2008-03 |
|
| Different regulation of T helper 1- and T helper 2-promoting cytokine signalling factors in human dendritic cells after exposure to protein versus contact allergens. | 2008-01 |
|
| Quantitative relationships between patch test reactivity and use test reactivity: an overview. | 2008 |
|
| Analysis of isothiazolinones in environmental waters by gas chromatography-mass spectrometry. | 2007-09-14 |
|
| Iron dependent degradation of an isothiazolone biocide (5-chloro-2-methyl-4-isothiazolin-3-one). | 2007 |
|
| Preservatives sensitivity in Israel: a 10-year overview (1995-2004). | 2006-10 |
|
| GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells. | 2006-02 |
|
| Patch testing with patients' own cosmetics and toiletries--results of the IVDK*, 1998-2002. | 2005-10 |
|
| Oxidative stress in mouse skin following application of contact allergenic 5-chloro-2-methyl-4-isothiazolin-3-one and oxazolone. | 2005-03 |
|
| From experiment to theory: molecular orbital parameters to interpret the skin sensitization potential of 5-chloro-2-methylisothiazol-3-one and 2-methylisothiazol-3-one. | 2005-02 |
|
| Effect of glutathione on the covalent binding of the 13C-labeled skin sensitizer 5-chloro-2-methylisothiazol-3-one to human serum albumin: identification of adducts by nuclear magnetic resonance, matrix-assisted laser desorption/ionization mass spectrometry, and nanoelectrospray tandem mass spectrometry. | 2004-09 |
|
| Covalent binding of the 13C-labeled skin sensitizers 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI) to a model peptide and glutathione. | 2004-01-19 |
|
| Contact sensitization to 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one in children. | 2003-10 |
|
| Co-existing sensitivity to metronidazole and isothiazolinone. | 2003-09 |
|
| Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal human keratinocytes. | 2003-08 |
|
| Studies of chemical selectivity of hapten, reactivity, and skin sensitization potency. 3. Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI). | 2003-05 |
|
| Coupling of contact sensitizers to thiol groups is a key event for the activation of monocytes and monocyte-derived dendritic cells. | 2003-02 |
|
| Audit of Finn Chamber patch test preparation. | 2002-12 |
|
| Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. | 2002-08-01 |
|
| Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000). | 2002-04 |
|
| In vitro induction of apoptosis vs. necrosis by widely used preservatives: 2-phenoxyethanol, a mixture of isothiazolinones, imidazolidinyl urea and 1,2-pentanediol. | 2002-02-01 |
Patents
Sample Use Guides
3 mcg of 5-chloro-2-methyl-4-isothiazolin-3-one (1.05% to 1.25% w/w) and 2-methyl-4-isothiazolin-3-one (0.25% to 0.40%w/w) in a 3:1 ratio per patch. Schedule patients to return approximately 48 hours after patch test application to have the panels removed.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6410231
Curator's Comment: Kathon is active at concentrations of 2.25–9 mg/mL active
ingredients against a wide range of bacteria and fungi.
https://www.google.ru/url?sa=t&rct=j&q=&esrc=s&source=web&cd=6&ved=0ahUKEwinisCBq8bPAhXI8ywKHWDrAJ8QFghGMAU&url=https%3A%2F%2Ffaculty.psau.edu.sa%2Ffiledownload%2Fdoc-7-pdf-61f3024ed641390e498517b310f7a378-original.pdf&usg=AFQjCNETPmioZMn6G6wNkDUJ6dSIgh59tA&sig2=uKNYTfPwwpRk83zu8Y96zA&bvm=bv.134495766,d.bGg
5-Chloro-2-methyl-4-isothiazolin-3-one inhibited growth in all test strains of Salmonella typhimurium without activation. A statistically significant increase in the number of revertants in strain TA100 was observed without activation at concentrations of 0.20, 0.25 and 0.30 ug/plate and in 2 of the 3 trials at 0.10 ug/plate.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:10:28 GMT 2025
by
admin
on
Mon Mar 31 18:10:28 GMT 2025
|
| Record UNII |
DEL7T5QRPN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 704
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 999
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 569
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
||
|
EPA PESTICIDE CODE |
107103
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 675
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
||
|
NDF-RT |
N0000185508
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
||
|
CFR |
21 CFR 176.170
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
||
|
CFR |
21 CFR 175.320
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C011421
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
SUB23424
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
DB14197
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
DEL7T5QRPN
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
1367119
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | RxNorm | ||
|
N0000175629
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | Increased Histamine Release [PE] | ||
|
m7433
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
100000088728
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
53621
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
33344
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
METHYLCHLOROISOTHIAZOLINONE
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
247-500-7
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
N0000171131
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
21 CFR 176.300
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
26172-55-4
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
N0000184306
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
8270
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
DTXSID9034286
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY | |||
|
DEL7T5QRPN
Created by
admin on Mon Mar 31 18:10:28 GMT 2025 , Edited by admin on Mon Mar 31 18:10:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |